SCHEMBL9508038

SCHEMBL9508038

CCCc1cc(C(=O)O)cc(CCC)c1OCCCCCCc1cccc(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.52
LTB4R Q15722 2/20 0.50
LTB4R2 Q9NPC1 1/20 0.50
KMT2A Q03164 1/20 0.45
ALOX5 P09917 1/20 0.42
PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510377 0.90 LTB4R (0.55) PPARALTB4RLTB4R2KMT2A
SCHEMBL9579690 0.88 LMNA (0.47) PPARALTB4RLTB4R2
SCHEMBL9510487 0.82 BID (0.48) PPARALTB4RLTB4R2
SCHEMBL9579709 0.80 LTB4R (0.46) PPARALTB4RLTB4R2
SCHEMBL3544218 0.78 ALOX5 (0.58) PPARAALOX5PTGS2
SCHEMBL3546860 0.78 TPMT (0.58) PPARAKMT2AALOX5PTGS2
SCHEMBL3547398 0.77 ALOX5 (0.57) PPARAALOX5PTGS2
SCHEMBL9506680 0.77 CYSLTR2 (0.52) PPARALTB4RLTB4R2KMT2AALOX5
SCHEMBL3546481 0.75 TPMT (0.55) PPARAKMT2AALOX5PTGS2
SCHEMBL15656477 0.75 ALOX5 (0.66) PPARAALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0310126-B1 DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES F. HOFFMANN-LA ROCHE AG (CH) 1993-08-18 EP disclosed
US-5191108-A Lipoxygenase inhibitors, antiinflammatory agents HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
US-5025036-A Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-06-18 US disclosed
EP-0310126-A2 Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines F. HOFFMANN-LA ROCHE AG (CH) 1989-04-05 EP disclosed